Acta Neurologica Scandinavica · 2008 · 54 citations · 14 references
Incomplete recovery at 1 month is a predictor of long-term persistence of RD. Higher relapse severity is associated with higher risk of RD. Risk of severe relapses is lower in patients treated with immunomodulating drugs.
14
Axonal Transection in the Lesions of Multiple Sclerosis
Bruce D. Trapp, John W. Peterson, Richard M. Ransohoff et al. · New England Journal of Medicine · 1998 · 4K citations · Full text
Defining the clinical course of multiple sclerosis
Fred Lublin, Stephen C. Reingold · Neurology · 1996 · 3.7K citations
Neurological Disorder, Patient Selection, Clinical Neurology +17
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
Neurology · 1993 · 2.1K citations
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
D. W. Paty, D.K.B. Li · Neurology · 1993 · 2K citations · Full text